https://www.selleckchem.com/pr....oducts/filanesib.htm
nd daily ingestion of a pill. This feasibility study informs future efforts to expand stroke TR. Clinical Trial Registration Clinicaltrials.gov, # NCT03460587.In the last 20 years, several modalities of neuromodulation, mainly based on non-invasive brain stimulation (NIBS) techniques, have been tested as a non-pharmacological therapeutic approach to slow disease progression in amyotrophic lateral sclerosis (ALS). In both sporadic and familial ALS cases, neurophysiological studies point to motor cortical hyperexcitability as a possible
Like
Comment
Share
